GlassScriptPhysician profile
William Hardin
NPI 1073508552
$4,211.32
in general payments reported to CMS, 2019-2025
10 companies · $860 in 2025
The $860 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $549 · 2022: $436 · 2023: $1,200 · 2024: $1,166 · 2025: $860.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,126 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,126.31 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $1,171.55 | 2021-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $950.30 | 2021-2025 | |
| Inspire Medical Systems, INC. | $892.78 | 2023-2025 | Inspire |
| Axsome Therapeutics, INC. | $753.79 | 2022-2025 | Sunosi |
| Idorsia Pharmaceuticals US INC | $126.14 | 2022-2024 | Quviviq |
| Eisai INC. | $100.77 | 2021-2022 | |
| Alcon Vision LLC | $93.13 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $70.07 | 2023-2025 | Lumryz |
| Arbor Pharmaceuticals, INC. | $39.43 | 2021 | |
| Apria Healthcare LLC | $13.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hardin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.